UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 281

Sortiert nach

Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial

The Lancet (British edition), 2017-03, Vol.389 (10075), p.1218-1228

2017

Volltextzugriff (PDF)

S2422 The Case of a Broken Heart: Mesalazine-Induced Myopericarditis Complicating Acute Severe Ulcerative Colitis

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S1026-S1026

2021

Volltextzugriff (PDF)

Safety, satisfaction and cost savings of accelerated infusions of standard and intensified‐dose infliximab for inflammatory bowel disease

Internal medicine journal, 2022-12, Vol.52 (12), p.2143-2149

2022

Volltextzugriff (PDF)

Therapeutic drug monitoring in inflammatory bowel disease reduces unnecessary use of infliximab with substantial associated cost‐savings

Internal medicine journal, 2021-05, Vol.51 (5), p.739-745

2021

Volltextzugriff (PDF)

Prospective randomised controlled trial of adults with perianal fistulising Crohn’s disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol

BMJ open, 2021-07, Vol.11 (7), p.e043921-e043921

2021

Volltextzugriff (PDF)

The effect of a nurse-led advice line and virtual clinic on inflammatory bowel disease service delivery: an Australian study

European journal of gastroenterology & hepatology, 2021-12, Vol.33 (1S Suppl 1), p.e771

2021

Volltextzugriff (PDF)

Comparison of infliximab drug measurement across three commercially available ELISA kits

Pathology, 2016-10, Vol.48 (6), p.608-612

2016

Volltextzugriff (PDF)

murine model of appendicitis and the impact of inflammation on appendiceal lymphocyte constituents

Clinical and experimental immunology, 2007-10, Vol.150 (1), p.169-178

2007

Volltextzugriff (PDF)

Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease

JGH open, 2021-09, Vol.5 (9), p.1063-1070

2021

Volltextzugriff (PDF)

Gastroenterologist perceptions of faecal microbiota transplantation

World journal of gastroenterology : WJG, 2015-10, Vol.21 (38), p.10907-10914

2015

Volltextzugriff (PDF)

Menetrier’s disease exacerbating ulcerative colitis and relieved by gastrectomy

BMJ open gastroenterology, 2021-12, Vol.8 (1), p.e000806

2021

Volltextzugriff (PDF)

Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab

Journal of Crohn's and colitis, 2012-07, Vol.6 (6), p.708-712

2012

Volltextzugriff (PDF)

Development and Feasibility of a Web-Based Decision Aid for Patients With Ulcerative Colitis: Qualitative Pilot Study

Journal of medical Internet research, 2021-02, Vol.23 (2), p.e15946-e15946

2021

Volltextzugriff (PDF)

Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2019-04, Vol.156 (5), p.1440-1454.e2

2019

Volltextzugriff (PDF)

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease

World journal of gastroenterology : WJG, 2022-06, Vol.28 (23), p.2597-2608

2022

Volltextzugriff (PDF)

Mo1834 DOSE ESCALATED VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1135-S-1135

2024

Volltextzugriff (PDF)

Su1841 VARIATION IN OUTCOMES IN INFLAMMATORY BOWEL DISEASE AT TEN AUSTRALASIAN CENTRES - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-839-S-839

2024

Volltextzugriff (PDF)

Su1782 QUALITY, SAFETY AND EQUITY OF CARE OUTCOMES FOR INFLAMMATORY BOWEL DISEASE PATIENTS AT FOUR AUSTRALIAN TERTIARY REFERRAL CENTRES USING THE CLOUD-BASED MANAGEMENT SYSTEM CROHN'S COLITIS CARE (CCCARE) : A REAL WORLD OBSERVATIONAL STUDY

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-679-S-679

2023

Volltextzugriff (PDF)

Sa1891 HIGHER INFLIXIMAB AND ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH FISTULA HEALING IN PATIENTS WITH FISTULISING PERIANAL CROHN'S DISEASE

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-467-S-468

2020

Volltextzugriff (PDF)

Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?

World journal of gastroenterology : WJG, 2021-03, Vol.27 (11), p.1090-1100

2021

Volltextzugriff (PDF)

Donor Recruitment for Fecal Microbiota Transplantation

Inflammatory bowel diseases, 2015-07, Vol.21 (7), p.1600-1606

2015

Volltextzugriff (PDF)

Su1659 – Positive Faecal Occult Blood Test After a Previous Negative Colonoscopy - to Scope Or Not?

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-601-S-601

2019

Volltextzugriff (PDF)

Su1760 CLINICAL AND ENDOSCOPIC REMISSION AT 3 MONTHS AFTER ACUTE SEVERE ULCERATIVE COLITIS IS PREDICTIVE OF MAINTENANCE THERAPY OUTCOMES AT 12 MONTHS - RESULTS FROM PREDICT UC

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-801-S-801

2024

Volltextzugriff (PDF)

900 PREDICT UC: OPTIMISING INFLIXIMAB INDUCTION THERAPY FOR ACUTE SEVERE ULCERATIVE COLITIS - A RANDOMISED CONTROLLED TRIAL

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-215-S-215

2024

Volltextzugriff (PDF)

Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease

Digestive diseases and sciences, 2023-03, Vol.68 (3), p.889-896

2023

Volltextzugriff (PDF)

1 – 25 von 281

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(245)
Mit Volltextzugriff
(250)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(179)
Life Sciences & Biomedicine
(144)
Humans
(106)
Female
(65)
Male
(58)
Adult
(45)
Middle Aged
(39)
Aged
(32)
Biological And Medical Sciences
(28)
Animals
(24)
Physical Sciences
(24)
Medical Sciences
(21)
Aged, 80 And Over
(19)
Patients
(19)
General & Internal Medicine
(17)
Medicine, General & Internal
(17)
Gastroenterology & Hepatology
(16)
Risk Factors
(16)
Science & Technology - Other Topics
(16)
Immunology
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial

S2422 The Case of a Broken Heart: Mesalazine-Induced Myopericarditis Complicating Acute Severe Ulcerative Colitis

Safety, satisfaction and cost savings of accelerated infusions of standard and intensified‐dose infliximab for inflammatory bowel disease

Therapeutic drug monitoring in inflammatory bowel disease reduces unnecessary use of infliximab with substantial associated cost‐savings

Prospective randomised controlled trial of adults with perianal fistulising Crohn’s disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol

The effect of a nurse-led advice line and virtual clinic on inflammatory bowel disease service delivery: an Australian study

Comparison of infliximab drug measurement across three commercially available ELISA kits

murine model of appendicitis and the impact of inflammation on appendiceal lymphocyte constituents

Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease

Gastroenterologist perceptions of faecal microbiota transplantation

Menetrier’s disease exacerbating ulcerative colitis and relieved by gastrectomy

Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab

Development and Feasibility of a Web-Based Decision Aid for Patients With Ulcerative Colitis: Qualitative Pilot Study

Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease

Mo1834 DOSE ESCALATED VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM

Su1841 VARIATION IN OUTCOMES IN INFLAMMATORY BOWEL DISEASE AT TEN AUSTRALASIAN CENTRES - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM

Su1782 QUALITY, SAFETY AND EQUITY OF CARE OUTCOMES FOR INFLAMMATORY BOWEL DISEASE PATIENTS AT FOUR AUSTRALIAN TERTIARY REFERRAL CENTRES USING THE CLOUD-BASED MANAGEMENT SYSTEM CROHN'S COLITIS CARE (CCCARE) : A REAL WORLD OBSERVATIONAL STUDY

Sa1891 HIGHER INFLIXIMAB AND ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH FISTULA HEALING IN PATIENTS WITH FISTULISING PERIANAL CROHN'S DISEASE

Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?

Donor Recruitment for Fecal Microbiota Transplantation

Su1659 – Positive Faecal Occult Blood Test After a Previous Negative Colonoscopy - to Scope Or Not?

Su1760 CLINICAL AND ENDOSCOPIC REMISSION AT 3 MONTHS AFTER ACUTE SEVERE ULCERATIVE COLITIS IS PREDICTIVE OF MAINTENANCE THERAPY OUTCOMES AT 12 MONTHS - RESULTS FROM PREDICT UC

900 PREDICT UC: OPTIMISING INFLIXIMAB INDUCTION THERAPY FOR ACUTE SEVERE ULCERATIVE COLITIS - A RANDOMISED CONTROLLED TRIAL

Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease

Suchergebnisse filtern